Galera Therapeutics CEO J Sorensen's 2023 pay slips 8% to $1.3M
Galera Therapeutics reports 2023 executive compensation
By ExecPay News
Published: 6 hours ago
Galera Therapeutics reported fiscal year 2023 executive compensation information on January 24, 2025.
In 2023, four executives at Galera Therapeutics received on average a compensation package of $837K, a 10% decrease compared to previous year.
Average pay of disclosed executives at Galera Therapeutics
J. Mel Sorensen, Chief Executive Officer, received $1.3M in total, which decreased by 8% compared to 2022. 49% of Sorensen's compensation, or $618K, was in option awards. Sorensen also received $617K in salary and $16K in other compensation.
Christopher Degnan, Chief Financial Officer, received a compensation package of $734K, which decreased by 12% compared to previous year. 63% of the compensation package, or $461K, was in salary.
Mark Bachleda, former Chief Commercial Officer, earned $711K in 2023, a 10% decrease compared to previous year.
Robert A. Beardsley, Chief Operating Officer, received $654K in 2023, which decreases by 14% compared to 2022.
Related executives
You may also like
Source: SEC filing on January 24, 2025.